|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1996-1-19
|
|
pubmed:abstractText |
A phase II study was undertaken to determine the efficacy of docetaxel in patients with metastatic malignant melanoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2895-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8523052-Adult,
pubmed-meshheading:8523052-Aged,
pubmed-meshheading:8523052-Aged, 80 and over,
pubmed-meshheading:8523052-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:8523052-Drug Administration Schedule,
pubmed-meshheading:8523052-Female,
pubmed-meshheading:8523052-Humans,
pubmed-meshheading:8523052-Infusions, Intravenous,
pubmed-meshheading:8523052-Male,
pubmed-meshheading:8523052-Melanoma,
pubmed-meshheading:8523052-Middle Aged,
pubmed-meshheading:8523052-Neoplasm Metastasis,
pubmed-meshheading:8523052-Paclitaxel,
pubmed-meshheading:8523052-Skin Neoplasms,
pubmed-meshheading:8523052-Taxoids
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.
|
|
pubmed:affiliation |
Department of Melanoma/Sarcoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
